Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today the issuance of a patent in Japan covering core innovations underlying its ...
Sam Altman, CEO of OpenAI, has made a compelling statement suggesting that humanity may be nearing the “singularity”—a critical juncture where artificial intelligence (AI) surpasses human intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results